Theoretical, experimental, and preclinical studies of heterogeneity-driven adaptive resistance to chemotherapy: Implications for multimodal targeted therapeutics
Theoretical, experimental, and preclinical studies of heterogeneity-driven adaptive resistance to chemotherapy: Implications for multimodal targeted therapeutics
异质性驱动的适应性化疗耐药的理论、实验和临床前研究：对多模式靶向治疗的影响
批准号：
381837
负责人：
Kohandel Mohammad
金额：
$53.5万
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2018
资助国家：
加拿大
项目状态：
已结题
起止时间：
2018-03-01 至 2021-03-01
中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
According to the Breast Cancer Society of Canada, in 2015, an estimated 25,000 Canadian women will be newly diagnosed with breast cancer and 5,000 will die from it. It is expected that 220 men will be diagnosed with breast cancer, while 60 will die from i
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金
